Rewiring Metal-Dependent Cell Death to Unlock Immunotherapy in Colorectal Cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41940591.
- Also identified by DOI 10.1021/acs.nanolett.6c00449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune checkpoint blockade (ICB) shows limited efficacy in colorectal cancer (CRC), particularly in microsatellite-stable tumors characterized by an immunologically "cold" microenvironment. Notably, the high metabolic demand for copper and iron in CRC, together with metal overload-associated PD-L1 upregulation, makes cuproptosis and ferroptosis attractive targets to enhance ICB responsiveness. Here, we present a laser-activated lipid nanoplatform, CuFeS<sub>2</sub>-CA-DAC-Lipo (CCDL), that orchestrates cuproptosis, ferroptosis, and pyroptosis while remodeling the tumor immune microenvironment. CuFeS<sub>2</sub> functions as a near-infrared II photothermal transducer and a source of copper and iron ions, inducing concurrent cuproptosis and ferroptosis via ion overload. Decitabine restores gasdermin E expression to couple oxidative stress with caspase-3-mediated pyroptosis, while chlorogenic acid repolarizes tumor-associated macrophages toward a pro-inflammatory phenotype. This coordinated multimodal cell-death cascade establishes a self-amplifying immunogenic circuit that suppresses tumor growth, sensitizes CRC to ICB, and elicits systemic antitumor immunity.
Medical subject headings
- Colorectal Neoplasms
- Immunotherapy
- Copper
- Iron
- Immune Checkpoint Inhibitors